This inventor holds 2 USPTO granted patents. Top assignee: Pierre Fabre Medicament. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Yvan Verscheure: Innovator in Pharmaceutical Chemistry
Introduction
Yvan Verscheure is a notable inventor based in Castres, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic applications. With a total of 2 patents to his name, Verscheure's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents is the invention titled "Substitute 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use." This invention concerns compounds of formula (I), where R1 and R2 can represent various alkyl radicals, and R3 to R8 can represent a range of functional groups. The patent also covers the therapeutically acceptable mineral or organic salts of these compounds and their possible hydrates. Another significant patent is for "Substituted 1-(4-piperidyl)-3-(aryl) isothioureas, their preparation and their therapeutic application," which further emphasizes his focus on innovative pharmaceutical solutions.
Career Highlights
Yvan Verscheure is currently associated with Pierre Fabre Medicament, a company known for its commitment to research and development in the pharmaceutical sector. His work at this institution has allowed him to explore and develop new therapeutic compounds that could benefit patients worldwide.
Collaborations
Throughout his career, Verscheure has collaborated with esteemed colleagues such as Jean-Pierre Rieu and Jean-François Patoiseau. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in pharmaceutical chemistry.
Conclusion
Yvan Verscheure's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in medicine.
